PATH vs RNXT
Uipath Inc (PATH) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the PATH and RNXT stock pages for the full models.
Not investment advice.